These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1754816)

  • 21. Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician's Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI; SDI).
    Lattanzi B; Consolaro A; Solari N; Ruperto N; Martini A; Ravelli A
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S112-7. PubMed ID: 22588739
    [No Abstract]   [Full Text] [Related]  

  • 22. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
    Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
    J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000.
    Yee CS; Isenberg DA; Prabu A; Sokoll K; Teh LS; Rahman A; Bruce IN; Griffiths B; Akil M; McHugh N; D'Cruz D; Khamashta MA; Maddison P; Zoma A; Gordon C
    Ann Rheum Dis; 2008 Jun; 67(6):873-6. PubMed ID: 17519277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Systemic Lupus Erythematosus Responder Index (SRI); a new SLE disease activity assessment.
    Luijten KM; Tekstra J; Bijlsma JW; Bijl M
    Autoimmun Rev; 2012 Mar; 11(5):326-9. PubMed ID: 21958603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic problems and evaluation of disease activity in systemic lupus erythematosus].
    Robak E; Kwiecień A; Sysa-Jedrzejowska A
    Przegl Lek; 2005; 62(5):299-305. PubMed ID: 16334536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties.
    Chessa E; Piga M; Floris A; Devilliers H; Cauli A; Arnaud L
    Rheumatology (Oxford); 2020 Dec; 59(12):3622-3632. PubMed ID: 32789462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.
    Ho A; Barr SG; Magder LS; Petri M
    Arthritis Rheum; 2001 Oct; 44(10):2350-7. PubMed ID: 11665976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus.
    Marks SD; Pilkington C; Woo P; Dillon MJ
    Rheumatology (Oxford); 2004 Sep; 43(9):1186-9. PubMed ID: 15226518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus.
    Bae SC; Koh HK; Chang DK; Kim MH; Park JK; Kim SY
    Lupus; 2001; 10(6):405-9. PubMed ID: 11434575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus.
    Ho A; Magder LS; Barr SG; Petri M
    Arthritis Rheum; 2001 Oct; 44(10):2342-9. PubMed ID: 11665975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI).
    Romero-Diaz J; Isenberg D; Ramsey-Goldman R
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11(0 11):S37-46. PubMed ID: 22588757
    [No Abstract]   [Full Text] [Related]  

  • 32. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus.
    Isenberg DA; Rahman A; Allen E; Farewell V; Akil M; Bruce IN; D'Cruz D; Griffiths B; Khamashta M; Maddison P; McHugh N; Snaith M; Teh LS; Yee CS; Zoma A; Gordon C
    Rheumatology (Oxford); 2005 Jul; 44(7):902-6. PubMed ID: 15814577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group.
    Wollaston SJ; Farewell VT; Isenberg DA; Gordon C; Merrill JT; Petri MA; Kalunian KC;
    J Rheumatol; 2004 Dec; 31(12):2390-4. PubMed ID: 15570639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic lupus erythematosus activity. An operational definition.
    Liang MH; Stern S; Esdaile JM
    Rheum Dis Clin North Am; 1988 Apr; 14(1):57-66. PubMed ID: 3135558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus.
    Stoll T; Stucki G; Malik J; Pyke S; Isenberg DA
    Ann Rheum Dis; 1996 Oct; 55(10):756-60. PubMed ID: 8984942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do lupus disease activity measures detect clinically important change?
    Fortin PR; Abrahamowicz M; Clarke AE; Neville C; Du Berger R; Fraenkel L; Liang MH
    J Rheumatol; 2000 Jun; 27(6):1421-8. PubMed ID: 10852264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a clinical chart to compute different disease activity indices for systemic lupus erythematosus.
    Vitali C; Bencivelli W; Mosca M; Carrai P; Sereni M; Bombardieri S
    J Rheumatol; 1999 Feb; 26(2):498-501. PubMed ID: 9972994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus.
    Gordon C; Wallace DJ; Shinada S; Kalunian KC; Forbess L; Braunstein GD; Weisman MH
    Rheumatology (Oxford); 2008 Mar; 47(3):334-8. PubMed ID: 18238794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two systemic lupus erythematosus (SLE) global disease activity indexes--the SLE Disease Activity Index and the Systemic Lupus Activity Measure--demonstrate different correlations with activation of peripheral blood CD4+ T cells.
    Daca A; Czuszyńska Z; Smoleńska Z; Zdrojewski Z; Witkowski JM; Bryl E
    Hum Immunol; 2011 Dec; 72(12):1160-7. PubMed ID: 21906646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
    Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.